Aprea Therapeutics stock price
아프레아 테라퓨틱스NASDAQ:APRE · Nasdaq · Healthcare$0.6950-3.94%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Aprea Therapeutics last closed at $0.6950 (-3.94%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -3.0×. Its overall grade ranks 466 of 739 stocks in Healthcare.
About this company
Aprea Therapeutics last closed at $0.6950 (-3.94%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C+ · 466/739
Valuation grade C+
Related stocks
- AstraZenecaCompetitor
ATRN-119 같은 DNA 손상 복구/종양 억제 표적 항암제 영역에서 경쟁 가능
- MerckCompetitor
항암제 및 고형암 치료제 개발 경쟁사로 동일한 종양학 파이프라인 경쟁
- Bristol Myers SquibbCompetitor
면역항암·종양학 신약 개발에서 대형 경쟁사
About Aprea Therapeutics
- What technical signals does Aprea Therapeutics (APRE) have?
- Aprea Therapeutics current technical signals: no active technical signal.
- Is Aprea Therapeutics a cup-and-handle pattern?
- No. Aprea Therapeutics has no valid Cup signal right now.
- What published figures are available for Aprea Therapeutics?
- Market cap: $4.39M. Trailing 12 months PER: -3.0×. Latest quarter PBR: 0.97×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Aprea Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy